RSH

0.00%

3.7¢ respiri limited

Ann: Preliminary Final Report, page-51

First 51 Last

Share
Profile

Follow
AdamC1986

92 Posts.

27

08/10/21

06:21

Post #: 56648408
Share

Originally posted by mondyinvest: ↑

Hello @lucasq thanks for responding, and likewise, I have enjoyed reading your posts. You were extremely helpful when I was first researching the company and I'm thankful for the information you provided at the time. I must apologise if I am coming across as a know-it-all, it certainly isn't the reality as, like most investors, there's always far more I don't know than what I do know. As mentioned previously I was happy to give the company time to get the product fully launched and Aussie sales coming in, but what changed for me was a combination of the very poor ADR bid and the guidance withdrawal. Since that time I've tried to look more objectively at the financials, letting the numbers do the talking rather than the narrative coming from the company, which I worried I could not completely trust. That's what prompts my posts like the second one on this thread above, as negative as it may sound. But yes my thinking certainly changed in mid-June, which I think is evidenced here: https://hotcopper.com.au/posts/53909151/single as well as here: https://hotcopper.com.au/posts/54251441/single. I gave it a lot of thought and elected that there were too many red flags so I had to abandon my 12-month timeline and quit early (which as a rule I tend not to do).

I've tried to document my thought processes because I enjoy constructive/honest discussion on stocks whether I hold it now or in the past. It's not a case of trying to be right - or hopefully shouldn't be. In fact, it would be fine to be proven wrong because that would help re-frame my views of Respiri, but taking this thread as an example, I've had no counter arguments to my first post above from the Respiri bulls, just one comment from AlCp. Unfortunately, as a general rule on HC, as soon as one's 'Position' changes to 'Not Held', it seems to be an automatic warrant for existing holders to stop engaging or write-off an opinion as downramping/bitter etc. Anyway, if my assumptions about the financial direction of the company are incorrect as you state, that's good news for everybody, me included. I can get back in at some suitable stage and hopefully see the company succeed.

Cheers
m

Expand

Hi @mondyinvest
I couldn't agree more you off all people came in with some good views and positivity on respiri however after the debacle of the Australian launch and a number of other failed actions on the management's behalf and as an investor it's not ok to discuss them???....i'm sorry but as an investor these things do need discussion otherwise there will be disgruntled investors with only assumptions and usually for the worse unless there is some kind of explanation or progressive news on the company which as we know there has been zero from respiri for the past 3 months!

RSH Price at posting: 6.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

The market's shrugged at China's stimulus measures all year. Why is this one different?

There are more pages in this discussion • 2 more messages in this thread...

First 51 Last

Add RSH (ASX) to my watchlist

(20min delay)
Last 3.7¢		Change 0.000(0.00%)		Mkt cap ! $47.53M

Open	High	Low	Value	Volume
3.6¢	3.7¢	3.6¢	$4.921K	135.6K

Buyers (Bids)

No.	Vol.	Price($)
2	80000	3.6¢

Sellers (Offers)

Price($)	Vol.	No.
3.7¢	45178	1

View Market Depth

No.	Vol.	Price($)
2	80000	0.036
4	353545	0.035
1	100000	0.034
2	100000	0.033
3	541370	0.032

Price($)	Vol.	No.
0.037	45178	1
0.038	515624	2
0.039	1482602	2
0.040	840000	3
0.042	882000	1

Last trade - 16.10pm 27/09/2024 (20 minute delay)

RSH (ASX) Chart

Ann: Preliminary Final Report, page-51

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Zeta Resources seeks to resolve the Panoramic takeover story

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

The market's shrugged at China's stimulus measures all year. Why is this one different?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Preliminary Final Report, page-51

Top Stories

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Zeta Resources seeks to resolve the Panoramic takeover story

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

The market's shrugged at China's stimulus measures all year. Why is this one different?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News